BRAENDER LORI J
Insider CIK 1752955 · AQST SVP, General Counsel
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AQST Aquestive Therapeutics, In | F Tax w/h | 2026-05-07 | 2026-05-11 | 135,690 | $4.23 | $574.0K | 231,042 | SEC↗ |
| AQST Aquestive Therapeutics, In | F Tax w/h | 2026-05-05 | 2026-05-07 | 76,147 | $4.18 | $318.3K | 366,732 | SEC↗ |
| AQST Aquestive Therapeutics, In | S Sale | 2026-03-10 | 2026-03-11 | 40,102 | $4.17 | $167.2K | 442,879 | SEC↗ |
| AQST Aquestive Therapeutics, In | A Award deriv | 2026-03-09 | 2026-03-11 | 50,000 | $4.29 | $214.5K | 50,000 | SEC↗ |
| AQST Aquestive Therapeutics, In | A Award | 2026-03-09 | 2026-03-11 | 80,000 | — | $0 | 482,981 | SEC↗ |
| AQST Aquestive Therapeutics, In | F Tax w/h | 2025-03-09 | 2025-03-11 | 10,658 | $2.65 | $28.2K | 402,981 | SEC↗ |
| AQST Aquestive Therapeutics, In | A Award deriv | 2025-03-07 | 2026-04-13 | 82,500 | — | $0 | 82,500 | SEC↗ |
| AQST Aquestive Therapeutics, In | A Award deriv | 2025-03-07 | 2025-03-11 | 60,000 | — | $0 | 60,000 | SEC↗ |
| AQST Aquestive Therapeutics, In | F Tax w/h | 2025-03-07 | 2025-03-11 | 9,592 | $2.65 | $25.4K | 413,639 | SEC↗ |
| AQST Aquestive Therapeutics, In | A Award | 2025-03-07 | 2025-03-11 | 110,000 | — | $0 | 423,231 | SEC↗ |
| AQST Aquestive Therapeutics, In | F Tax w/h | 2024-03-09 | 2024-03-12 | 10,530 | $4.88 | $51.4K | 313,231 | SEC↗ |
| AQST Aquestive Therapeutics, In | A Award deriv | 2024-03-07 | 2024-03-11 | 67,500 | — | $0 | 67,500 | SEC↗ |
| AQST Aquestive Therapeutics, In | A Award | 2024-03-07 | 2024-03-11 | 135,000 | — | $0 | 323,761 | SEC↗ |
| AQST Aquestive Therapeutics, In | A Award deriv | 2023-08-09 | 2023-08-09 | 75,000 | — | $0 | 75,000 | SEC↗ |
| AQST Aquestive Therapeutics, In | A Award deriv | 2023-05-05 | 2023-05-05 | 75,000 | — | $0 | 75,000 | SEC↗ |
| AQST Aquestive Therapeutics, In | A Award | 2023-03-09 | 2023-03-09 | 150,000 | — | $0 | 188,761 | SEC↗ |
| AQST Aquestive Therapeutics, In | A Award deriv | 2022-11-04 | 2022-11-08 | 40,000 | — | $0 | 40,000 | SEC↗ |
| AQST Aquestive Therapeutics, In | P Buy deriv | 2022-06-08 | 2022-06-10 | 13,761 | $0.13 | $1.8K | 13,761 | SEC↗ |
| AQST Aquestive Therapeutics, In | P Buy | 2022-06-08 | 2022-06-10 | 13,761 | $0.96 | $13.2K | 38,761 | SEC↗ |
| AQST Aquestive Therapeutics, In | A Award deriv | 2022-03-10 | 2022-03-14 | 160,000 | — | $0 | 160,000 | SEC↗ |
| AQST Aquestive Therapeutics, In | A Award deriv | 2021-03-11 | 2021-03-15 | 75,000 | — | $0 | 75,000 | SEC↗ |
| AQST Aquestive Therapeutics, In | A Award deriv | 2020-03-16 | 2020-03-18 | 60,000 | — | $0 | 60,000 | SEC↗ |
| AQST Aquestive Therapeutics, In | P Buy | 2020-03-16 | 2020-03-18 | 14,000 | $1.54 | $21.6K | 25,000 | SEC↗ |
| AQST Aquestive Therapeutics, In | P Buy | 2019-08-09 | 2019-08-13 | 10,000 | $4.07 | $40.7K | 11,000 | SEC↗ |
| AQST Aquestive Therapeutics, In | A Award deriv | 2019-02-28 | 2019-03-04 | 100,000 | — | $0 | 100,000 | SEC↗ |
| AQST Aquestive Therapeutics, In | P Buy | 2018-11-27 | 2018-11-29 | 1,000 | $10.57 | $10.6K | 1,000 | SEC↗ |
| AQST Aquestive Therapeutics, In | A Award deriv | 2018-09-10 | 2018-09-13 | 85,000 | — | $0 | 85,000 | SEC↗ |